[DOI] [PMC free article] [PubMed] [Google Scholar] [84].Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S, Daeron M, Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses, Blood, 113 (2009) 37163725
Stephanie Lambson, quoted by ACMT, noted that compounded vial-based products introduce particular risk because they lack the auto-calibrated pen mechanism of the branded products: "It's up to the patients to draw out the correct amount of medication to administer to themselves, and this is where we've seen a lot of the errors." What the Evidence Shows and What It Does Not MedicalDaily Evidence Check Study type: Retrospective analysis of national poison center database records (20122023) Participants: All reported GLP-1 receptor agonist exposures in national poison center data Published in: Journal of Medical Toxicology (2026), Volume 22, pages 275285 (DOI: 10.1007/s13181-026-01121-z) What it found: Poison control calls involving semaglutide surged more than five-fold after FDA weight-loss approval
Trang, B and Chen, E
Select Treatment: Your Program Summary: Initial Telehealth Visit Prescription + Medication Unlimited Physician Support Monthly Check-ins $897.00 / per 3 month $9.96 / DAY Cancel anytime No commitments Why Choose Us
